IP Library Granted Patent US 9,778,490
Granted Patent B2
US 9,778,490 · App. 13/551,341 · Granted Oct 3, 2017

Therapeutic eyewear

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,778,490
App. No.
13/551,341
Granted
Oct 3, 2017
Kind
B2
Abstract

The embodiments disclosed herein relate to a transparent material to provide protection to a person's eyes from harmful wavelengths of the light spectrum, overall visual comfort, or improved vision such as color enhancement, target recognition and other functions, while selectively transmitting more of certain wavelengths of the light spectrum that have a therapeutic benefit such as healing or general mood modifier. The transparent material may be a lens or a shield which is disposed in front of the wearer's eyes.

Claims (20)

1. An eyewear for providing therapeutic effects while being worn in sunlight, the eyewear comprising:

a lens which allows two ranges of therapeutic wavelengths of light therethrough;

wherein an average light transmittance of the lens at the wavelength range of 460 nm to 510 nm is 3 or more times the average light transmittance of the lens at the wavelength range of 400 nm to 450 nm for therapeutically affecting a wearer's circadian rhythm;

wherein the average light transmittance of the lens for the range of 460-510 nm is 30% or more than an average light transmittance for the range of 520 nm-560 nm, a maximum light transmittance within the range of 460 nm to 510 nm being at 470 nm to 495 nm to facilitate transmittance of a therapeutic portion of the blue light through the lens and a minimum light transmittance within the range of 540 nm to 600 nm being no less than 0.2 luminous transmittance, light transmittance of the lens starts to increase at or below 600 nm to facilitate transmittance of a full spectrum of red light through the lens, and an average light transmittance for the range between 650 nm to 850 nm is 2 or more times an average overall light transmittance of the lens for perceptively darkening a scene viewed through the lens and stimulating cells of the wearer with red and near-infrared wavelengths of light.

2. An eyewear for providing therapeutic effects while being worn in sunlight, the eyewear comprising:

a lens which allows two ranges of therapeutic wavelengths of light therethrough;

wherein an average light transmittance of the lens at the wavelength range of 450 nm to 510 nm is 2 or more times the average light transmittance of the lens at the wavelength range of 400 nm to 450 nm to facilitate transmittance of a therapeutic portion of the blue light through the lens for therapeutically affecting a wearer's circadian rhythm, light transmittance through the lens starts to increase at or below 600 nm to facilitate transmittance of a full spectrum of red light through the lens, and an average light transmittance in the range of 650 nm to 850 nm is about 2 or more times an average overall lens percent transmittance for perceptively darkening a scene viewed through the lens and stimulating cells with red and near-infrared wavelengths of light.

3. The eyewear of claim 1 wherein the lens blocks substantially all wavelengths below 400 nm.

4. The eyewear of claim 3 wherein light transmittance through the lens increases as the wavelength increases from 400 nm to 450 nm.

5. The eyewear of claim 1 wherein an overall luminous transmittance value of the lens is 8% to 15%.

6. The eyewear of claim 1 wherein an overall luminous transmittance value of the lens is 16% to 25%.

7. The eyewear of claim 1 wherein an overall luminous transmittance value of the lens is 25% to 50%.

8. An eyewear for providing therapeutic effects while being worn in sunlight, the eyewear comprising:

a lens which allows two ranges of therapeutic wavelengths of light therethrough;

wherein an average light transmittance of the lens at the wavelength range of 450 nm to 510 nm is 2 or more times the average light transmittance of the lens at the wavelength range of 400 nm to 450 nm to facilitate transmittance of a therapeutic portion of the blue light through the lens for therapeutically affecting a wearer's circadian rhythm;

wherein the average light transmittance of the lens for the range of 450-50 nm is 20% or more than an average light transmittance for the range of 520 nm-580 nm, a maximum light transmittance within the range of 450 nm to 510 nm being at 460 nm to 510 nm and a minimum light transmittance within the range of 500 nm to 600 nm being no less than 0.2 luminous transmittance, light transmittance of the lens starts to increase at or below 600 nm to facilitate transmittance of a full spectrum of red light through the lens, and an average light transmittance for the range between 650 nm to 850 nm is 2 or more times an average overall light transmittance of the lens for perceptively darkening a scene viewed through the lens and stimulating cells with red and near-infrared wavelengths of light.

9. An eyewear for providing therapeutic effects while being worn in sunlight, the eyewear comprising:

a lens which allows two ranges of therapeutic wavelengths of light therethrough;

wherein an average light transmittance of the lens at a wavelength range of 450 nm to 510 nm is 2 or more times the average light transmittance of the lens at a wavelength range of 400 nm to 450 nm to facilitate transmittance of a therapeutic portion of the blue light through the lens for therapeutically affecting a wearer's circadian rhythm;

wherein the light transmittance of the lens at 450-510 nm is 20% or more than an average light transmittance for the range of 500 nm-600 nm, the light transmittance has a relative maximum at 470 nm to 480 nm within the range of 450 nm to 510 nm, the light transmittance is substantially attenuated in the range of 510 nm-600 nm with a minimum transmittance within the range of 510 nm to 600 nm no less than 0.2 luminous transmittance, and light transmittance through the lens starts to increase at or below 600 nm to facilitate transmittance of a full spectrum of red light through the lens and an average light transmittance for the range between 650 nm to 850 nm is 2 or more times an average overall light transmittance of the lens for perceptively darkening the scene viewed through the lens and stimulating cells with red and near-infrared wavelengths of light.

Assignments (7)
MERGER Recorded Aug 21, 2023
From: SPY INC.
To: BOLLE BRANDS INC.
Reel/Frame 064652/0516 →
MERGER Recorded May 1, 2023
From: SPY OPTIC INC.
To: SPY INC.
Reel/Frame 063493/0302 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2020
From: SIENA LENDING GROUP LLC
To: SPY OPTIC INC.
Reel/Frame 053830/0374 →
SECURITY INTEREST Recorded Apr 5, 2019
From: SPY OPTIC INC.
To: SIENA LENDING GROUP LLC
Reel/Frame 048809/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2012
From: PRITTS, JAMES E.
To: SPY OPTIC INC.
Reel/Frame 029139/0505 →
CHANGE OF NAME Recorded Aug 29, 2012
From: ORANGE 21 NORTH AMERICA INC.
To: SPY OPTIC INC.
Reel/Frame 028868/0701 →
INDEPENDENT CONTRACTOR AGREEMENT/CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT Recorded Aug 28, 2012
From: PRITTS, JAMES E.
To: ORANGE 21 NORTH AMERICA INC.
Reel/Frame 028859/0327 →